We offer a breadth of expertise and research experience, and have been involved in the design and evaluation of over one hundred Phase 1 studies, including more than 50 abuse liability studies, as well as first-in-man, pharmacokinetic, drug/alcohol interaction and proof of concept studies.
We provide scientific, regulatory and operational input on abuse liability assessments for new chemical entities (NCE) and abuse-deterrent formulations (ADF). We can help you at all premarket stages of program or study development, from initial planning up until the regulatory submission.
General Inquiries:
Email: contact@altreos.com